0001209191-23-020244.txt : 20230321 0001209191-23-020244.hdr.sgml : 20230321 20230321162113 ACCESSION NUMBER: 0001209191-23-020244 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230317 FILED AS OF DATE: 20230321 DATE AS OF CHANGE: 20230321 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: WAGNER CHARLES F JR CENTRAL INDEX KEY: 0001223348 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19319 FILM NUMBER: 23749978 MAIL ADDRESS: STREET 1: C/O MILLIPORE CORP CITY: BILLERICA STATE: MA ZIP: 01820 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA CENTRAL INDEX KEY: 0000875320 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043039129 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: 6173416393 MAIL ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 4 1 doc4.xml FORM 4 SUBMISSION X0407 4 2023-03-17 0 0000875320 VERTEX PHARMACEUTICALS INC / MA VRTX 0001223348 WAGNER CHARLES F JR C/O VERTEX PHARMACEUTICALS INCORPORATED 50 NORTHERN AVENUE BOSTON MA 02210 0 1 0 0 EVP & Chief Financial Officer 1 Common Stock 2023-03-17 4 S 0 360 294.52 D 53019 D Common Stock 2023-03-17 4 S 0 784 295.43 D 52235 D Common Stock 2023-03-17 4 S 0 240 296.30 D 51995 D Common Stock 2023-03-17 4 S 0 360 298.09 D 51635 D Common Stock 2023-03-17 4 S 0 240 299.58 D 51395 D Common Stock 2023-03-17 4 S 0 16 301.13 D 51379 D Transaction made pursuant to Mr. Wagner's company approved trading plan under Rule 10b5-1, which was adopted on 08/08/2022. Mr. Wagner undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Open market sales reported on this line occurred at a weighted average price of $294.52 (range $293.98 to $294.81). Open market sales reported on this line occurred at a weighted average price of $295.43 (range $295.09 to $295.97). Open market sales reported on this line occurred at a weighted average price of $296.30 (range $296.14 to $296.45). Open market sales reported on this line occurred at a weighted average price of $298.09 (range $297.65 to $298.48). Open market sales reported on this line occurred at a weighted average price of $299.58 (range $299.09 to $300.06). /s/ Christiana Stevenson, Attorney-in-Fact 2023-03-21